Tips

Ê®ÔÂ×ðÁú¿­Ê±½«Ö÷Àí2³¡ÏßÉÏÖ±²¥£¬Í¬Ê±¼ÓÈë9³¡º£ÄÚÍâÐÐÒµ¾Û»á£¬ÆÚ´ýÓëÁÐλҵÄÚͬÈʽ»Á÷·ÖÏíÒ©ÎïÑз¢ÐÂÇ÷ÊÆ¡£

22^nd San Diego Biopharma Conference

Join Medicilon at the 22^nd San Diego Biopharma Conference in the beautiful San Diego.

This time, you can not only visit our table, but also focus the speech ¡°Medicilon Drug Discovery Cutting Edge Technology Platforms¡± by President of Medicilon USA Corp., Dr. Qingcong Lin.

APA 2024

We are excited to announce that Medicilon will exhibit at the Applied Pharmaceutical Analysis (APA) 2024 in Cambridge, MA. We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities. 

Dr. Peggy Teng, Executive Director BD Operations of MEDICILON USA CORP., will give a speaking at 2:25 - 3:05 local time on October 8. We sincerely invite you to visit us at Medicilon Booth #3!

16^th Drug Discovery Strategic Summit

This time let's meet in San Francisco!

16^th Drug Discovery Strategic Summit is coming! Medicilon team will be present throughout the conference.  We look forward to meeting you. Medicilon is experienced with oncology drug in any preclinical phases, from hit-to-lead to IND. We provide integrated service strategies for sponsors' oncology drug discovery and development pipelines. We aim to enhance every step in preclinical search and to deliver real time data.

BioJapan 2024

£¨½øÈë¾Û»á¹ÙÍø£ºhttps://jcd-expo.jp/en/£¬Ïàʶ¸ü¶à£©

±¾´Î´ó»á½«ÓÚ½ñÄê10ÔÂ9ÈÕÖÁ11ÈÕÔÚÈÕ±¾ºá±õÊеÄPACIFICO Yokohama¾ÙÐÐ¡£

×ðÁú¿­Ê±ÍŶӽ«ÔÚB-82È«³ÌÉèÕ¹£¬³ÏÑûÄúÝ°ÁÙÏÖ³¡Ò»¶ÔÒ»½»Á÷£¡

The 46^th  KSNS Workshop

The 46th Korean Society of Nonclinical Study (KSNS) Workshop is only two weeks to go! Medicilon is excited to exhibit in the conference. Dr. Hanjun Zou, TFM of Medicilon Chuansha site, and Medicilon KoreanTeam will be available at Medicilon Booth #43. Dr. Zou has more than 17 years of experience in toxicity and preclinical safety assessment with most career working in multinational companies. Dr. Zou is also a certified toxicologist (DCST, ERT & DABT) in China, Europe and the United States.

We are getting ready. Are you?

2024Öйú(Ìì½ò)¹ú¼ÊÉúÎïÒ½Ò©¹¤ÒµÕ¹ÀÀ»á

2024Äê10ÔÂ18ÈÕ-20ÈÕ£¬Ò»ÄêÒ»¶ÈµÄ¹ú¼ÊÉúÎïÒ½Ò©´ó»á¡ª¡ª2024Öйú(Ìì½ò)¹ú¼ÊÉúÎïÒ½Ò©¹¤ÒµÕ¹ÀÀ»á£¨BIOME2024£©½«ÔÚ¹ú¼Ò»áÕ¹ÖÐÐÄ(Ìì½ò)¾ÙÐÐ¡£

×ðÁú¿­Ê±½«ÔÚÏÖ³¡ÉèÕ¹£¬³ÏÑûÄúÝ°ÁÙ½»Á÷£¡

AAPS 2024 PHarmSCi 360

Troubled by your current problems with drug discovery? Meet Medicilon at AAPS 2024 PHarmSCi 360! It kicks off on October 20 in Salt Lake City. Medicilon team will be present in person at Medicilon Booth #1526! Maybe Medicilon can help you solve your current problem and become a partner of choice! Medicilon is continuedly advancing our technology platforms constantly, collaborating closely with our global clients to deliver demanding and innovative novel drug research.

17^th Drug Discovery Strategic Summit

Medicilon is thrilled to exhibit in the 17^th Drug Discovery Strategic Summit. The summit will take place from 23 to 24 October 2024 at Munich, Germany. Dr. Paul van Stralen, VP of Strategic Collaborations EMEA at Medicilon, will be available throughout the conference. We invite you to visit us at Medicilon Booth #6 to explore our services and capabilities.

µÚ¶þ½ìÈÜÁö²¡¶¾Á¢ÒìÓëÏàÖú´ó»á

Ϊ½øÒ»²½Íƶ¯ÈÜÁö²¡¶¾Ò©ÎïÁÙ´²Ñз¢£¬Ôö½øÈÜÁö²¡¶¾ÁìÓòÈ«Á´Ìõ½»Á÷ÓëÏàÖú£¬ÓÉÖйúÒ½Ò©Á¢ÒìÔö½ø»á¡¢Î人¶«ºþÐÂÊÖÒÕ¿ª·¢ÇøÖÎÀíίԱ»á¡¢°¬ÃÀ´ïÒ½Ò©×ÉѯºÍ±õ»áÉúÎïµÈ»ú¹¹ÅäºÏ×éÖ¯µÄµÚ¶þ½ìÈÜÁö²¡¶¾Á¢ÒìÓëÏàÖú´ó»á¶¨ÓÚ2024Äê10ÔÂ26~27ÈÕÔÚºþ±±Î人¾ÙÐÐ¡£

×ðÁú¿­Ê±ÍŶӽ«ÔÚB20չλÉèÕ¹£¬³ÏÑûÄúÝ°ÁÙ½»Á÷£¡×ðÁú¿­Ê±Ê×ϯ¿Æѧ¹ÙÅíË«Ç彫ÔÚÏÖ³¡·¢Ñݳö½²£¡

marketing@medicilon.com.cn
ýÌåÓë»áÎñÇëÁªÏµ
×ðÁú¿­Ê±Êг¡²¿Î¢ÐÅ»òÓÊÏä